<code id='F5A2BF3CA5'></code><style id='F5A2BF3CA5'></style>
    • <acronym id='F5A2BF3CA5'></acronym>
      <center id='F5A2BF3CA5'><center id='F5A2BF3CA5'><tfoot id='F5A2BF3CA5'></tfoot></center><abbr id='F5A2BF3CA5'><dir id='F5A2BF3CA5'><tfoot id='F5A2BF3CA5'></tfoot><noframes id='F5A2BF3CA5'>

    • <optgroup id='F5A2BF3CA5'><strike id='F5A2BF3CA5'><sup id='F5A2BF3CA5'></sup></strike><code id='F5A2BF3CA5'></code></optgroup>
        1. <b id='F5A2BF3CA5'><label id='F5A2BF3CA5'><select id='F5A2BF3CA5'><dt id='F5A2BF3CA5'><span id='F5A2BF3CA5'></span></dt></select></label></b><u id='F5A2BF3CA5'></u>
          <i id='F5A2BF3CA5'><strike id='F5A2BF3CA5'><tt id='F5A2BF3CA5'><pre id='F5A2BF3CA5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:81
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

          CourtesyBristolMyersSquibbWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Medtronic CEO on promising devices for diabetes, hypertension

          GeoffMartha,CEOofMedtronicCourtesyMedtronicAsoneofthelargestandoldestmedicaldevicecompaniesintheworl